UPS opens medical and biotechnology logistics center

UPS opens medical and biotechnology logistics center

UPS has announced that it is expanding the capabilities of its European temperature-controlled supply chain by opening an air freight center at Amsterdam Airport Schiphol in the Netherlands, specializing in medical shipments. The opening of the new center confirms UPS’s commitment to developing its offering for specialized market segments, in this case, logistics support for medical and biotechnology companies.

The new 600 sqm facility meets GDP requirements and has been designed to the highest standards for pharmaceutical transport. The building features temperature zones from 15ºC to 25ºC and from 2ºC to 8ºC, as well as monitoring and alarm systems that ensure the protection of temperature-sensitive medical shipments. UPS operators undergo detailed training and follow procedures specifically prepared for medical logistics to ensure that products entering and leaving the facility remain safe during transport.

– Due to the increasing volume of biological preparations, temperature-sensitive products, as well as changing regulations regarding pharmaceutical transport in various regions of the world, companies need control and more effective protection of their products during transport – said John Menna, UPS Vice President of Global Strategy for Healthcare Logistics. – The new biotechnology center at Amsterdam Airport Schiphol allows us to strictly control the temperature of shipments in accordance with the requirements set out in EU GDP guidelines.

Thanks to its own facility dedicated to medical logistics and meeting GDP requirements at Amsterdam Airport Schiphol, UPS provides greater control over the handling and temporary storage of medical shipments, which helps customers reduce risk and meet stringent quality standards. The new UPS center enables the use of insulated pallets and the monitoring of actively controlled containers. UPS staff are trained to ensure proper handling and compliance with packaging supplier instructions.
The latest UPS investment comes six months after the company announced the acquisition of the Polish company Poltraf Sp. z o.o., which specializes in the distribution of pharmaceutical products. This transaction expands the reach of UPS’s European medical logistics, enabling the provision of services to customers in medical markets in Central and Eastern Europe. As a result of the acquisition, the existing European UPS medical logistics network has grown by three facilities with advanced warehouse management systems, quality assurance services, and the UPS team has gained experienced personnel.
UPS offers medical and biotechnology companies a wide range of specialized freight, transport, and distribution services. The UPS medical logistics network also provides 24/7 monitoring and security, picking and labeling, as well as order management and customer billing services. Services at all locations are available through a single, global IT platform for order management. UPS helps medical companies meet stringent, often complex regulatory requirements, offers flexibility in a changing business environment, and serves an ever-growing group of international clients.